Changing landscape of superficial and invasive mycoses

13:15 • 2397 • Non-dermatophyte filamentous fungal isolation in nail samples: results from 5 years of cultures > S. Sara GÓMEZ DE FRUTOS (Madrid) 13:20 • 2184 • COVID-19-associated pulmonary aspergillosis: a multi-centre, observational cohort study involving 823 patients > N. Nico JANSSEN (Nijmegen) 13:25 • 2664 • Gastrointestinal mucormycosis: analysis of 55 cases from the FungiScope® registry > E. Ertan SAL (Cologne) 13:30 • 1790 • Cutaneous mucormycosis: analysis of 70 cases from a global registry (www.zygomyco.net) > A. Anna SKIADA (Athens) 13:35 • 1827 • Epidemiology of candidaemia in Swiss tertiary care hospitals: a 15-year survey, 2004 to 2018 > K-M. Kai-Manuel ADAM (Basel) 13:40 • 1368 • <em>Candida glabrata</em> single- and multidrug-resistance: a five-year analysis of clinical samples from German healthcare facilities > A. Alexander Maximilian ALDEJOHANN (Würzburg) 13:45 • 1875 • <em>In vitro</em> antifungal activity of manogepix and registered antifungal agents against South African <em>Candida auris </em>isolates from bloodstream infections > T. Tsidiso Gugu MAPHANGA (Johannesburg) 13:50 • 1764 • Azole resistance in <em>Aspergillus fumigatus: </em>the first 2-year data from the Danish nationwide surveillance study > M. Malene RISUM (Copenhagen) 13:55 • 2185 • EUCAST susceptibility and squalene epoxidase sequencing of Danish <em>Trichophyton</em> <em>rubrum </em>and <em>Trichophyton interdigitale </em>isolates 2019-2020 suggest worrisome levels of terbinafine resistance. > K. Karen Marie ASTVAD (Valby) 14:00 • INT85 • Q&A/Discussion